MEDizzy
MEDizzy
Amy Kosran
Amy Kosran8 months ago
FDA Approves Mirikizumab for Ulcerative Colitis

FDA Approves Mirikizumab for Ulcerative Colitis

Mirikizumab (Omvoh) is the first IL-23 inhibitor to be approved in the United States for the treament of moderately to severely active ulcerative colitis.

Source: https://www.medscape.com/viewarticle/997822?src=mbl_msp_android&ref=share
1
Other commentsSign in to post comments. You don't have an account? Sign up now!

Recent MCQs















Show more MCQs

Recent flashcard sets















Show more flashcards